532 related articles for article (PubMed ID: 10338336)
1. Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein.
Kageshita T; Matsui T; Hirai S; Fukuda Y; Ono T
Melanoma Res; 1999 Feb; 9(1):69-73. PubMed ID: 10338336
[TBL] [Abstract][Full Text] [Related]
2. Widespread expression of parathyroid hormone-related peptide in melanocytic cells.
Kageshita T; Ishihara T; Tokuo H; Funasaka Y; Ichihashi M; Dong J; Nakajima M; Ono T
Br J Dermatol; 2003 Mar; 148(3):533-8. PubMed ID: 12653746
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.
Attia P; Phan GQ; Duray PH; Rosenberg SA
Am J Clin Oncol; 2003 Feb; 26(1):42-5. PubMed ID: 12576923
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcaemia and elevated levels of parathyroid hormone-related protein in cutaneous squamous/basal cell carcinoma.
Marino MT; Asp AA; Budayer AA; Marsden JS; Strewler GJ
J Intern Med; 1993 Feb; 233(2):205-7. PubMed ID: 8433083
[TBL] [Abstract][Full Text] [Related]
6. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
7. Primary hyperparathyroidism or hypercalcaemia of malignancy?
Birkeland KI; Gallefoss F; Olsson S; Haug E
Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.
Michigami T; Yamato H; Mushiake S; Nakayama M; Yoneda A; Satomura K; Imura K; Ozono K
J Clin Endocrinol Metab; 1996 Mar; 81(3):1090-5. PubMed ID: 8772581
[TBL] [Abstract][Full Text] [Related]
9. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia.
Pandian MR; Morgan CH; Carlton E; Segre GV
Clin Chem; 1992 Feb; 38(2):282-8. PubMed ID: 1371724
[TBL] [Abstract][Full Text] [Related]
10. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
[TBL] [Abstract][Full Text] [Related]
11. [Melanoma and primary hyperparathyroidism].
Maerens-Tchokokam B; Bailly N; Collet E; Dalac S; Rat P; Lambert D
Ann Dermatol Venereol; 1993; 120(3):215-7. PubMed ID: 8239359
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy.
Firkin F; Seymour JF; Watson AM; Grill V; Martin TJ
Br J Haematol; 1996 Sep; 94(3):486-92. PubMed ID: 8790147
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein and hypercalcemia.
Rankin W; Grill V; Martin TJ
Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcaemia in small cell lung cancer: report of a case associated with parathyroid hormone-related protein (PTHrP).
Stuart-Harris R; Ahern V; Danks JA; Gurney H; Martin TJ
Eur J Cancer; 1993; 29A(11):1601-4. PubMed ID: 8217368
[TBL] [Abstract][Full Text] [Related]
15. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
Wimalawansa SJ
Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
[TBL] [Abstract][Full Text] [Related]
17. PTH-independent hypercalcaemia and non-melanoma skin cancer.
Nicolae I; Schipor S
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):449-52. PubMed ID: 19778357
[TBL] [Abstract][Full Text] [Related]
18. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
Hutchesson AC; Bundred NJ; Ratcliffe WA
Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
[TBL] [Abstract][Full Text] [Related]
19. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone related protein in hypercalcaemia of Hodgkin's disease.
Bolo-Deoku J; Basu S; Lakhani S; Dunne F; Ratcliffe WA; Clarke M; Barron JL
J Clin Pathol; 1992 Jun; 45(6):541-2. PubMed ID: 1624608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
